This is The Seed Investors weekly wrap-up of major news from the cannabis industry and our analysis of the important trends.
Most cannabis impaired-driving laws in North America are based upon a laughable misunderstanding of simple science. They WILL get struck down.
The U.S. Food and Drug Administration is claiming that CBD poses significant risks to the human liver. Nonsense.
Quebec's provincial government suffers from acute anti-cannabis paranoia. Chicken Little pseudo-science like this doesn't help.
A top Mexican senator reaffirmed on Monday that his chamber considers marijuana reform a major priority in the coming legislative session.
This is The Seed Investor's weekly wrap up of major news from the cannabis industry and our analysis of the important trends.
The Food and Drug Administration (FDA) recently announced a policy change that will expedite the marketing of marijuana testing devices if they’re used for certain purposes.
As the U.S. Cannabis Revolution unfolds, over 90% of Americans now want cannabis legalized (at least) for medical purposes. Attention Congress.
A measure to legalize medical marijuana in Mississippi has officially qualified for the November ballot.
A cannabis-based potential treatment for leukemia is seen as a promising (and lucrative) area of biopharma research.